FREE UK DELIVERY OVER £100 MADE TO ORDER THIRD-PARTY TESTED UK BASED SUPPORT EARN WITH APEXION PARTNERS
MELANOCORTIN RESEARCH

PT-141 10MG

One pre-filled 10mg PT-141 research pen for laboratory studies of cell signalling.

4.9 · 20 Google reviews Research grade
£89.99Free UK tracked delivery from £100
  • Made fresh to order
  • Batch documentation pending
  • UK tracked delivery
  • Order by 1pm on working days for same-day dispatch
  • Results published when verified

Research Use Only

PT-141 10mg (bremelanotide) is a synthetic cyclic heptapeptide that acts on melanocortin receptors, supplied in one pre-filled research pen. Every PT-141 pen is prepared to order in the UK and shipped cold chain by tracked delivery.

PT-141 is closely related to MT2 (Melanotan II): it shares MT2’s ring structure but ends in a free carboxylic acid instead of an amide. Our research compound guide covers other melanocortin peptides, including KPV.

How PT-141 is studied

PT-141 is an agonist mainly at the MC4R and MC3R melanocortin receptors, which are found in the hypothalamus and other brain regions. Research has focused on how central melanocortin signalling influences behaviour, using rodent behavioural models. It has also been developed elsewhere as a medicine, and reviews describe its clinical pharmacology.

5 key research areas

  1. MC4R and MC3R pharmacology. PT-141 is studied as an agonist at the central melanocortin receptors MC4R and MC3R.
  2. Central nervous system signalling. Studies examine how melanocortin pathways in the hypothalamus influence behaviour.
  3. Rodent behavioural models. Female rat studies examined the effect of melanocortin receptor activation on sexual behaviour.
  4. Structure-activity relationships. Its relationship to MT2 is used to compare how small structural changes affect receptor activity.
  5. Clinical development. Reviews summarise its development as a medicine elsewhere; this product is research material only.

Selected published research

Peer-reviewed studies and reviews on PT-141, with PubMed IDs:

  1. Molinoff PB, et al. (2003). PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Annals of the New York Academy of Sciences. PMID 12851303
  2. Pfaus JG, et al. (2004). Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proceedings of the National Academy of Sciences of the USA. PMID 15226502
  3. Hadley ME, Dorr RT (2006). Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. PMID 16412534
  4. Dhillon S, Keam SJ (2019). Bremelanotide: first approval. Drugs. PMID 31429064

These references describe laboratory, animal and clinical research on PT-141 (bremelanotide). They are cited as scientific background only and do not make this research material suitable for human use.

What arrives

10mg pen
One pre-filled Apexion research pen
Single compound
PT-141 (bremelanotide), cyclic melanocortin peptide
Protected packaging
Discreet and tamper-evident
Batch traceability
Batch number on every pen; independent testing in progress

Preparation and UK dispatch

  • Made fresh to order after checkout
  • Prepared and quality checked before dispatch
  • Tracked Royal Mail delivery across the UK
  • UK-based product and documentation support

Simple, secure checkout

Pay by Bank is the preferred option
Card payments are temporarily unavailable.

Independent testing is in progress; results will be published only when verified evidence is available.

Research use only. This product is supplied for in-vitro laboratory research by qualified researchers. It is not a medicine, is not licensed by the MHRA, and is not intended for human or veterinary use, diagnosis or treatment.

Research gradeLaboratory use only
Analytical statusIndependent testing in progress; results published on verification
Research use onlyNot for human consumption
Product presentation
PT-141 10MG

Upsell

Frequently bought together

Bundle price

£161.98

£179.98

Save £18.00

Cross-sell

You may also like

WhatsApp us